Back to Search
Start Over
Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.
- Source :
-
European journal of pharmacology [Eur J Pharmacol] 2021 Sep 05; Vol. 906, pp. 174263. Date of Electronic Publication: 2021 Jun 16. - Publication Year :
- 2021
-
Abstract
- Sigma-2 receptor/transmembrane protein 97 (TMEM97) is upregulated in cancer cells compared to normal cells. Traditional sigma-2 receptor agonists induce apoptosis and autophagy, making them of interest in cancer therapy. Recently, we reported a novel metabolically stimulative function of the sigma-2 receptor, showing increased 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction and stimulation of glycolytic hallmarks. 6-Substituted analogs of the canonical sigma-2 receptor antagonist, 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), produce both metabolically stimulative and cytotoxic effects. Here, we compare the activities of two related compounds: 6-amino-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (CM571), the 6-amino derivative of SN79, which binds with high affinity to both sigma-1 and sigma-2 receptors, and 1,3-bis(3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)-2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)thiourea (MAM03055A), a homo-bivalent dimer of CM571. MAM03055A resulted from the degradation of 3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)-6-isothiocyanatobenzo[d]oxazol-2(3H)-one (CM572), the cytotoxic 6-isothiocyanato SN79 derivative. MAM03055A exhibited high affinity and strong preference for sigma-2 receptors (sigma-1 K <subscript>i</subscript>  = 3371 nM; sigma-2 receptor K <subscript>i</subscript>  = 55.9 nM). Functionally, MAM03055A treatment potently induced cell death in SK-N-SH neuroblastoma, MDA-MB-231 breast, and both SW48 and SW480 colorectal cancer cell lines, causing proapoptotic BH3 interacting-domain death agonist (BID) cleavage in SK-N-SH cells. Conversely, CM571 induced metabolic stimulation. CM571 bound reversibly to both receptors, while MAM03055A bound pseudo-irreversibly to sigma-2 receptors and caused residual cytotoxic activity after acute exposure and removal of the compound from the media. Interestingly, MAM03055A induced a time-dependent loss of sigma-2 receptor/TMEM97 protein from cells, whereas monomer CM571 had no effect on receptor levels. These results suggest that monovalent and bivalent sigma-2 receptor ligands in this series interact differently with the receptor, thus resulting in divergent effects.<br /> (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Subjects :
- Antineoplastic Agents therapeutic use
Benzoxazoles pharmacology
Benzoxazoles therapeutic use
Cell Line, Tumor
Cell Survival drug effects
Drug Screening Assays, Antitumor
Humans
Isocyanates pharmacology
Isocyanates therapeutic use
Membrane Proteins metabolism
Neoplasms pathology
Receptors, sigma metabolism
Antineoplastic Agents pharmacology
Membrane Proteins antagonists & inhibitors
Neoplasms drug therapy
Receptors, sigma antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0712
- Volume :
- 906
- Database :
- MEDLINE
- Journal :
- European journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 34144027
- Full Text :
- https://doi.org/10.1016/j.ejphar.2021.174263